The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
Pearson, D. C., May, G. R., Fick, G. H., & Sutherland, L. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00009 · Cited by 950
“Proving the null hypothesis” in clinical trials
Blackwelder, W. C. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90024-1 · Cited by 887
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Self-citationLow-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Markowitz, J., Grancher, K., Kohn, N., Lesser, M., & Daum, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.18144 · Cited by 716
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
Fraser, A. G. (2002) · Gut · doi:10.1136/gut.50.4.485 · Cited by 629
A controlled double blind study of azathioprine in the management of Crohn's disease.
Candy, S., Wright, J., Gerber, M., Adams, G., Gerig, M., & Goodman, R. (1995) · Gut · doi:10.1136/gut.37.5.674 · Cited by 567
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)
Best, W. R., Becktel, J. M., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90384-6 · Cited by 562
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
Connell, W. R., Kamm, M. A., Ritchie, J. K., & Lennard-Jones, J. E. (1993) · Gut · doi:10.1136/gut.34.8.1081 · Cited by 510
Weedon, D. D., Shorter, R. G., Ilstrup, D. M., Huizenga, K. A., & Taylor, W. F. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311222892101 · Cited by 467
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
Bouhnik, Y., Scemama, G., Taï, R., Matuchansky, C., Rambaud, J.-C., Lémann, M., Modigliani, R., & Mary, J.-Y. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90402-x · Cited by 466
Self-citationSmoking cessation and the course of Crohn's disease: An intervention study
Cosnes, J., Beaugerie, L., Carbonnel, F., & Gendre, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.23231 · Cited by 431
Lallemant, M., Jourdain, G., Le Coeur, S., Kim, S., Koetsawang, S., Comeau, A. M., Phoolcharoen, W., Essex, M., McIntosh, K., & Vithayasai, V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431401 · Cited by 425
Dunnett, C. W., & Gent, M. (1977) · Biometrics · doi:10.2307/2529457 · Cited by 389
Crohn's disease and cancer: A population-based cohort study
Persson, P.-G., Karlén, P., Bernell, O., Leijonmarck, C.-E., Broström, O., Ahlbom, A., & Hellers, G. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90807-9 · Cited by 306
Azathioprine for maintenance of remission in Crohn's disease
Pearson, D., May, G., Fick, G., & Sutherland, L. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067 · Cited by 304
Dayharsh, G. A., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Zinsmeister, A. R., Witzig, T. E., Macon, W. R., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.30328 · Cited by 275
Farrell, R. J., Ang, Y., Kileen, P., O'Briain, D. S., Kelleher, D., Keeling, P. W. N., & Weir, D. G. (2000) · Gut · doi:10.1136/gut.47.4.514 · Cited by 260
Bartko, J. J. (1991) · American Psychologist · doi:10.1037//0003-066x.46.10.1089.a · Cited by 249
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
Lewis, J. D., Schwartz, J. S., & Lichtenstein, G. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70353-2 · Cited by 242
The relationship between infliximab treatment and lymphoma in Crohn's disease
Bickston, S. J., Lichtenstein, G. R., Arseneau, K. O., Cohen, R. B., & Cominelli, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70294-5 · Cited by 203
Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
Fraser, A. G., Orchard, T. R., Robinson, E. M., & Jewell, D. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01297.x · Cited by 198
Risk of lymphoma in inflammatory bowel disease
Loftus, E. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01108-4 · Cited by 173
Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine
Korelitz, B. I., Mirsky, F. J., Fleisher, M. R., Warman, J. I., Wisch, N., & Gleim, G. W. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01530.x · Cited by 134
Epstein-Barr Virus–Positive Primary Gastrointestinal Hodgkin's Disease
Kumar, S., Fend, F., Quintanilla‐Martínez, L., Kingma, D. W., Sorbara, L. R., Raffeld, M. A., Banks, P. M., & Jaffe, E. S. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00008 · Cited by 126
Posthuma, E. F. M., Westendorp, R. G. J., Veer, A. V. D. S., Kluin‐Nelemans, H. C., Kluin, P. M., & Lamers, C. B. H. W. (1995) · Gut · doi:10.1136/gut.36.2.311 · Cited by 93
Optimum Duration of Treatment With 6-Mercaptopurine for Crohn's Disease
Kim, P. S.-H., Zlatanic, J., Korelitz, B. I., & Gleim, G. W. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01532.x · Cited by 79
Brignola, C., lannone, P., Belloli, C., Simone, G. D., Bassein, L., Gionchetti, P., Belluzzi, A., Campieri, M., & Barbara, L. (1994) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199410000-00020 · Cited by 33
An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
Khatchatourian, M., & Seaton, T. (1997) · PubMed · Cited by 26
Biological markers of short term relapse in Crohn's disease (CD)
Consigny, Y., Modigliani, R., Colombel, J. F., Dupas, J. L., & Mary, J. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)80693-2 · Cited by 21
Self-citation
Cited by
Epidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Dignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
Self-citationGuidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Metadata
- Authors
- Lémann, M., Mary, J.-Y., Colombel, J.-F., Duclos, B., Soule, J.-C., Lerebours, E., Modigliani, R., & Bouhnik, Y.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 128
- Issue
- 7
- Pages
- 1812-1818
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2014523285
- Cited by
- 349
- References
- 32
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.